ONdrugDelivery provides >30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition.
External link for ONdrugDelivery
The Candlemakers
Lewes, East Sussex BN7 2NZ, GB
ONdrugDelivery reposted this
Interesting article recently published in the November issue of On Drug Delivery by my colleague Mark Ignaczak on choosing a CDMO for nasal drug delivery. Be sure to meet up with us in Booth #205 at Drug Delivery to the Lungs Conference (DDL) in Edinburgh for any of your nasal needs
In which issues should your company appear? ONdrugDelivery's 2025 Media Pack is out. Download the Media Pack PDF here 👉 https://lnkd.in/eWfzh3hV **20th Anniversary Year!** 2025 is ONdrugDelivery’s 20th Anniversary Year and we have exciting plans in store during the year to celebrate, including: - In January we launch our superb brand new look design for our print magazine - We’ve designed five new promotional packages : “Outstanding“, “Enhanced“, “Classic“, “Showcase” and “Essential Presence” (full details inside the Media Pack) - In 2H 2025 we'll launch an all new website - In 4Q 2025 we’ll launch two new issue topics for ONdrugDelivery – “Dual Chamber Delivery Systems” and “Delivering Gene & Cell Therapies“ We can’t wait for this exciting two-decades milestone year to start, and we’d love you to be with us! Take the first step towards gaining a presence in the leading publication of its kind covering the global drug delivery industry. Download our Media Pack PDF👉https://lnkd.in/eWfzh3hV
ONdrugDelivery reposted this
Excited to announce the publication of our latest article in ONdrugDelivery’s November 2024 issue! 🎉 Discover how Aptar Pharma's PureHale® technology is revolutionizing targeted delivery of your formulations to the upper airways with its advanced fine mist delivery system. Designed for targeted deposition to the upper respiratory tract, PureHale® offers fine mist dispensing for non-chemical OTC products, such as saline formulations, that meet consumer needs for natural, non-invasive respiratory care. Read more about consumer needs in respiratory care that PureHale® addresses in a targeted way https://ow.ly/LVa050U5RyQ Kudos to authors Julien Storz-Sontheimer and Giulia Müller for their insightful contributions! #FineMist #UpperAirways #SalineFormulations #TargetedDeposition #AptarPharma
ONdrugDelivery reposted this
#ICYMI: In their #ExpertView piece in the ONdrugDelivery November issue of Pulmonary & Nasal Drug Delivery, Beyond Air's Chief Commercial Officer, David Webster, and VP of Clinical Affairs, Mark Rimkus RRT, P.Eng, explore how generating nitric oxide (NO) at the bedside could address the environmental challenges posed by traditional generation methods. 🌎 Read the full article here ➡️ https://lnkd.in/gwwEQdMt Check out the entire issue here ➡️ https://lnkd.in/dVTzC3WP #BeyondAir #RespiratoryCare #Innovation #NitricOxide #Sustainability #PatientCare
The latest ONdrugDelivery is out! - Issue 167, Nov 2024, focuses 100% on "PULMONARY & NASAL DRUG DELIVERY" from cover-to-cover. Read it here 👉 https://lnkd.in/dVTzC3WP Opening with nasal delivery, Mark Ignaczak of Catalent Pharma Solutions provides an overview of the current nasal delivery landscape and what to consider when choosing a CDMO to ensure nasal product programme success. Then a series of articles highlight a diverse range of pulmonary delivery devices. Hernan Cuevas Brun and Yuchi Chen discuss how the combination of Formosa Pharmaceuticals, Inc.’s patented APNT nanotechnology formulation platform with HCmed Innovations Co., Ltd.’s AdheResp smart breath-actuated nebuliser can enhance respiratory drug delivery empower developers to deliver difficult solution-based formulations to the lung reliably. Fredrik Bokvist of VivoLab AB introduces the Breease pacifier – a solution to the effects of air pollution on young children and infants – and, along with Marie-Christine Klein and Christian Weyler, looks forward to combining Breease with URSATEC GmbH’s Softbreezer inhaler to enhance the technology with moisturising therapy. In their interview, Julien Storz-Sontheimer and Giulia Müller, discuss Aptar Pharma’s PureHale system for delivering a fine mist to the upper airways, including its reception by consumers and applications in the current respiratory landscape. Andrea Cusack, Elijah Nazarzadeh, and John Pritchard provide insights into Nebu~Flow ’s innovative nebuliser platform based on patented ultrasound technology, covering how nebulisers are well positioned to fulfil unmet needs in the respiratory market and how Nebu~Flow aims to tackle the factors that may have thus far held them back. Looking at the new USP <1604> chapter, Clair Brooks of Copley Scientific contributes an in-depth overview of how these changes to the regulatory landscape affect the gathering and analysis of cascade impactor data. Sustainability also features prominently, with Alastair Willoughby of Team Consulting tackling decarbonising drug delivery in an interview discussing his talk at CHPI 2024. In their Expert View piece, David Webster and Mark Rimkus RRT, P.Eng of Beyond Air® discuss how generating NO at patient’s bedsides could be the solution to tackling the environmental challenges presented by current generation methods. The issue also contains a robust look at HFA-152a and HFO-1234ze, the primary low-GWP candidates to replace current pMDI propellants, with articles from Ross Errington and Simon Gardner at Bespak; Nicholas Smalley at Kindeva Drug Delivery; and, in an Expert View, Mark Parry, John McLaughlin, and Tino Otte of Intertek Melbourn each offering their own valuable insight into this topical issue. Access the full issue's content here 👉 https://lnkd.in/dVTzC3WP #drugdelivery #inhalation #respiratory #nasalspray #nebuliser #mdi #inhalers #devices
ONdrugDelivery reposted this
🔥 Fresh insights from our team! Dive into our latest article in ONdrugDelivery, where our Applications Specialist, Clair Brooks, explores how APSD metrics in OINDP testing can be quantified and compared. Discover calculation methods, including those introduced in USP <1604>, and compare “standard” vs. efficient data analysis metrics. Gain a deeper understanding to apply these methods effectively in everyday testing. 📑 Read it here: bit.ly/4evyXWq #Innovation #ODDmagazine #Article #Compliance #Pharma #InhalerTesting #DrivingResults #Pharmaceuticals #Formulations #USP<1604> #DataAnalysis
ONdrugDelivery reposted this
Check out Aptar's latest article in ONdrugDelivery’s November 2024 issue! 🫁 It explores how Aptar Pharma’s PureHale® technology is transforming the targeted delivery of formulations to the upper airways with its innovative fine mist system. PureHale® is designed for precise deposition in the upper respiratory tract, offering fine mist dispensing for non-chemical OTC products like saline formulations, catering to consumer demands for natural and non-invasive respiratory care. Dive into the details of how PureHale® meets consumer needs in respiratory care: https://ow.ly/LVa050U5RyQ #FineMist #UpperAirways #SalineFormulations #TargetedDeposition #AptarPharma
ONdrugDelivery reposted this
Mark Ignaczak shares his insights with ONdrugDelivery on the current nasal drug delivery landscape and outlines key considerations for choosing the right CDMO to ensure the success of nasal drug projects. Read the article here: https://ow.ly/weP150U9yXq
ONdrugDelivery reposted this
On #WorldCOPDday we want to raise awareness that the race to adopt low Global Warming Potential (#GWP) #propellants is on! An industry-wide transition to climate-friendly propellants for pressurised Metered Dose Inhalers (#pMDIs) is gaining momentum. To safeguard the accessibility of life-saving medicines and avoid disruption to business continuity, pharmaceutical companies will need to re-evaluate formulations, device components and manufacturing processes. In the latest issue of ONdrugDelivery, Ross Errington, Head of Drug Product Development at Bespak, and Simon Gardner Business Development Director, draw on data and expertise to explore this complex landscape. From legislative timelines to what’s driving future supply chains, read more to discover how you can get ahead of the curve. Link: https://lnkd.in/eihZrytD #Bespak #Sustainability #Pharma #InhalationDevices #pMDI #LowGWP #ClimatefriendlyPropellants #DrugDelivery #CDMO
ONdrugDelivery reposted this
Breathing Innovation into November! This November, we’re proud to be featured in ONdrugDelivery Magazine's Pulmonary & Nasal Drug Delivery edition, which focuses on one of RPK Medical’s key markets. December promises even more as we prepare to showcase our expertise at the prestigious Drug Delivery to the Lungs Conference (DDL). Together, we’re contributing to better respiratory health for people worldwide. 🔗 https://lnkd.in/eReWnKSF #RPKMedical #WeAreRPKGroup #DDL2024 #MedicalInnovation #MedicalDevices Guy Furness
ONdrugDelivery reposted this
✨ Formosa Pharmaceuticals, Inc. is thrilled to announce that our breakthrough case study, *"Improving Aerosol Delivery: Nanosuspension and Mesh Technology,"* led by Dr. YuChi Chen, our Director of Nanotechnology Development, has been published in the latest *ONdrugDelivery* Issue No. 167! A huge thanks to our partners at HCmed Innovations Co., Ltd. for collaborating with us to demonstrate how APNT nanoparticle technology enables efficient suspension delivery using the advanced AdheResp smart breath-actuated mesh nebulizer. This publication marks an exciting milestone in aerosol delivery innovation! ✨ Learn More - https://shorturl.at/HITPj #APNT #AdheResp #ONdrugDelivery #Nanosuspension